Global X Genomics & Biotechnology ETF (GNOM) Short Interest Ratio & Short Volume

Short interest is the volume of Global X Genomics & Biotechnology ETF shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 18,600 shares of GNOM short. Learn More on Global X Genomics & Biotechnology ETF's current short interest.

Global X Genomics & Biotechnology ETF saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 18,600 shares, an increase of 69.1% from the previous total of 11,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies compare to Global X Genomics & Biotechnology ETF: Wahed Dow Jones Islamic World ETF (0.09%), WisdomTree Cybersecurity Fund (0.12%), Valkyrie Bitcoin Miners ETF (8.15%), First Trust Indxx Innovative Transaction & Process ETF (0.05%), ERShares Entrepreneurs ETF (0.01%), VanEck Digital Transformation ETF (2.42%), SPDR MSCI ACWI Climate Paris Aligned ETF (0.56%), iShares ESG Advanced MSCI EM ETF (0.93%), Global X E-Commerce ETF (0.02%), Spear Alpha ETF (0.55%),

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

Short selling GNOM is an investing strategy that aims to generate trading profit from Global X Genomics & Biotechnology ETF as its price is falling. GNOM shares are trading up $0.19 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Global X Genomics & Biotechnology ETF occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GNOM, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GNOM, twice per month. The most recent reporting period available is April, 30 2024.